Hikma Pharmaceuticals Plc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.
/ 
Frequently asked questions
To buy Hikma Pharmaceuticals Plc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Hikma Pharmaceuticals Plc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Hikma Pharmaceuticals Plc is HIK:xlon. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Hikma Pharmaceuticals Plc has its primary listing on London Stock Exchange. You can trade Hikma Pharmaceuticals Plc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Hikma Pharmaceuticals Plc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Hikma Pharmaceuticals Plc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Hikma Pharmaceuticals Plc.